Ledger.Open graph →
SEC Form D · filed March 17, 2023

Eumentis Therapeutics, Inc

Offering
$20.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Randall Marshall · Newton, MAExecMark Tepper · Newton, MAExec · DirectorAndrew Pearlman · Newton, MADirectorJames Larrick · Newton, MADirectorMaryann Bryla · Newton, MADirectorKim Patrick · Newton, MADirectorThomas Roeder · Nantucket, MADirectorIlon R. Wu · New York, NYDirectorMats N. Eklund · St Helier, Y9DirectorCarsten D. Koppen · St Helier, Y9Exec · DirectorMichael Baran · San Diego, CADirectorAdrian Bot · San Diego, CAExecSteve B. Kim · San Mateo, CADirectorS. C. Honig · San Mateo, CAExec · DirectorRobby Peters · San Mateo, CADirectorAndrew E. Braithwaite · Salt Lake City, UTExecSophia Dilbert · Grand Cayman, Cayman IslandsDirectorClaude Radoux · Grand Duchy of Luxembourg, LuxembourgDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗